Cargando…
General anesthesia, using remimazolam, for the patient with myelin oligodendrocyte glycoprotein antibody associated disease (MOGAD): A case report
Myelin oligodendrocyte glycoprotein antibody associated disease (MOGAD) is one of auto-immune demyelinating diseases of nervous system. Although both regional anesthesia and general anesthesia has been successfully performed in the patient with demyelinating diseases of nervous system, it has been c...
Autores principales: | Hong, Seung-Wan, Kim, Byung-Soo, Park, Sang-Tae, Jeong, Hae-Chang, Hwang, Min-Sik, Kim, Seong-Hyop |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9678535/ https://www.ncbi.nlm.nih.gov/pubmed/36401433 http://dx.doi.org/10.1097/MD.0000000000031734 |
Ejemplares similares
-
Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): current understanding and challenges
por: Al-Ani, Abdullah, et al.
Publicado: (2023) -
Remimazolam sedation with regional anesthesia in difficult airway due to huge thyroid goiter: A case report
por: Kim, Gwanbeom, et al.
Publicado: (2023) -
High fever in myelin oligodendrocyte
glycoprotein-associated disorder (MOGAD):
A diagnostic challenge
por: Azar, Chadi, et al.
Publicado: (2023) -
Clinical Features and Imaging Findings of Myelin Oligodendrocyte Glycoprotein-IgG-Associated Disorder (MOGAD)
por: Li, Yunjie, et al.
Publicado: (2022) -
Low mortality rate in a large cohort of myelin oligodendrocyte glycoprotein antibody disease (MOGAD)
por: Lotan, Itay, et al.
Publicado: (2023)